Cargando…
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic effects comparable to their parental cells and are considered promising agents for the treatment of a variety of diseases. To this end, strategies must be designed to successfully translate EV research and to de...
Autores principales: | Gimona, Mario, Pachler, Karin, Laner-Plamberger, Sandra, Schallmoser, Katharina, Rohde, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486013/ https://www.ncbi.nlm.nih.gov/pubmed/28587212 http://dx.doi.org/10.3390/ijms18061190 |
Ejemplares similares
-
An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles
por: Pachler, Karin, et al.
Publicado: (2017) -
Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo
por: Warnecke, Athanasia, et al.
Publicado: (2020) -
Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production
por: Oeller, Michaela, et al.
Publicado: (2021) -
First‐in‐human intracochlear application of human stromal cell‐derived extracellular vesicles
por: Warnecke, Athanasia, et al.
Publicado: (2021) -
Heparin and Derivatives for Advanced Cell Therapies
por: Laner-Plamberger, Sandra, et al.
Publicado: (2021)